期刊文献+

Study on the relationship of IL-12 and IL-4 levels with macroangiopathy in type 2 diabetes mellitus

下载PDF
导出
摘要 Objective:To study the relationship of interleukin-12(IL-12)and IL-4 levels with macroangiopathy in type 2 diabetes mellitus by comparing the serum IL-12 and IL-4 levels and intima-media thickness(IMT)between the healthy controls and the type 2 diabetic patients with or without macroangiopathy.Methods:30 healthy controls and 120 cases with type 2 diabetes mellitus from November 2011 to November 2012 were selected.In accordance with the carotid intima-media thickness,the type 2 diabetes mellitus patients were divided into group A with IMT below 1.0 mm,group B with IMT between 1.0 mm and 1.2 mm,group C with IMT between 1.2 mm and 1.4 mm,group D with IMT over 1.4 mm.ELISA was used to measure the levels of serum IL-12 and IL-4 in all groups.And the measurement results of serum IL-12 and IL-4 levels in the groups were compared.Results:Type 2 diabetes mellitus groups had significantly higher serum IL-12 levels and much lower IL-4 levels than the healthy control group.In the type 2 diabetes mellitus groups,the thicker the IMT was,the higher the incidence of complications became.IL-12 level was positively correlated with IMT while the IL-4 level was negatively correlated with IMT.Conclusions:IL-12 levels in patients with type 2 diabetes were significantly higher and IL-4 levels were significantly lower than those in the healthy people.In patients with type 2 diabetes,the IL-12 levels increased while the IL-4 levels gradually declined with the advance of macroangiopathy.
出处 《Discussion of Clinical Cases》 2016年第3期12-15,共4页 临床病例讨论杂志(英文版)
  • 相关文献

参考文献2

二级参考文献11

  • 1[1]Eguchi K,Yagame M,Suzuki D et al.Significance of high level of serum IgA and IgA-classcirculating immune complexes (IgA-CIC) in patients with non-insulin dependent diabetes mellitus[J].J Diabetes Complication,1995 ;9(1):42-48.
  • 2[2]Barbara M,Brooks-Worrell,Rattan Juneja et al.Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients[J].Diabetes,1999;48(5):983-988.
  • 3[3]Mosmann T R,Coffman R l.Th1 and Th2 cella different fatterns of lymphokine secretion lead to different functional properties[J].Annu Rev Immunol,1989;7:145-173.
  • 4[4]Mosmann T R,Sad S.The expanding universe of T-cell subets:Th1,Th2 and more[J].Immunol Today,1996;17(3):138-146.
  • 5[5]Katz J D,Benoist C,Mathis D T et al.helper cell subsets in insulindependent diabetes[J].Sicience,1995 ;268(5214):1185-1188.
  • 6[6]Almawi W Y,Tamin H,Azar S T.Clinical review 103:T helper type 1 and 2 cytokines mediate the onsetand progression of type 1 (insulin dependent) diabetes[J].J Clin Endocrinol Metab,1999;84(5):1497-1502.
  • 7[7]John A,Colwell M D.Inflammation and diabetic vascular complications[J].Diabetes Care,1999;22(12):1927-1928.
  • 8[8]Ford ES.Body mass index,diabetes,and c-reactive protein among U S adults[J].Diabetes Care,1999;22(12):1971-1977.
  • 9[9]Barzilay J I,Abaham I,Heckbert S R et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study[J].Diabetes,2001 ;50(10):2384-2389.
  • 10[10]Pradhan A D,Manson J E,Rifai N et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus[J].JAMA,2001 ;286(3):327-334.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部